"Pharmacovigilance" - monitoring all drugs on the market to identify previously undetected side effects - is therefore vital and Parliament is set to approve an extensive update to EU rules, improving the early detection of rogue side effects to enhance patient safety.
Izveidot Eiropas Sistēmisko risku komiteju, kas pārraudzīs Eiropas mēroga riskus, piemēram, pārāk daudz lētas naudas, vaļīgus aizdevuma standartus vai ekonomikas līdzsvara traucējumus.